Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

C.M. Zwaan, D Reinhardt, M. Zimmerman, H Hasle, J Stary, B. Stark, M Dworzak, U. Creutzig, G.J.L. Kaspers

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)768-776
JournalBritish Journal of Haematology
Issue number5
Publication statusPublished - 2010

Cite this